Myriad Genetics (MYGN) stock was upgraded to Overweight by Piper Sandler, citing a balanced risk-reward set up for its beaten ...

Atlas Energy Solutions launched at Piper Sandler with an Overweight rating, attracted to multiple growth avenues, ...

Proficio Capital Partners LLC acquired a new position in Piper Sandler Companies (NYSE:PIPR – Free Report) in the 4th quarter ...

M&T Bank Corp reduced its holdings in shares of Piper Sandler Companies (NYSE:PIPR – Free Report) by 13.6% during the 4th ...

Artificial intelligence took the tech world by storm at the end of 2022, with the introduction of ChatGPT and generative AI. The past few years ...

Piper Sandler expects the bill to pass along party lines. "Once it makes it over to the Senate, at least eight Democrats will ...

Fintel reports that on March 12, 2025, Piper Sandler upgraded their outlook for Myriad Genetics (NasdaqGS:MYGN) from Neutral ...

In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Nektar Therapeutics (NKTR – Research Report), with a ...

Learn more about whether Janus Henderson Group plc or Piper Sandler Companies is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Short sellers have been increasing their bets, with short interest now accounting for 6.1% of the stock's available float.

The revised estimates put Wall Street's average year-end target for the S&P 500 at 6,607, implying an advance of more than 17% from Friday's close of 5,638.94, according to a recent survey of Wall ...

For two consecutive years, stock-market prognosticators lifted their outlooks for the S&P 500 Index over and over again to ...